$ 6.89
Key Takeaways
Risk factor
Meaningful price volatility
Profitability factor
Undervalued vs peers
About
Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment (DME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and...
Company Valuation
From both historical and forecast perspectives, the stock is underpriced compared to similar stocks. Specifically, the stock is fairly valued on P/E, undervalued on EV/EB
Target Price
The average target price of VMD is 13 and suggests 94% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increase
